That letter was from Cargill, and the part referencing BioAmber was “background.” PWC sold BioAmber’s interests in that patent to LCYB in the liquidation, but Cargill says their deal with BioAmber has clauses in it that give them sole ownership in the event of default. That’s what it’s about. If LCYB chooses to assert the ownership interests that BioAmber had (and they bought), they’ll likely have to litigate it, could go either way since Cargill should have come into CCAA and cited those clauses and had the patents affected removed from the listing.
LCYB can make a deal with Cargill, too, if they lose and need to use the patents.
News 
Market Data 
Discover 
